3700 studies found for:    Japan
Show Display Options
Rank Status Study
1 Recruiting Study of Efficacy and Safety of LCZ696 in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction
Condition: Heart Failure With Reduced Ejection Fraction (HF-rEF)
Interventions: Drug: LCZ696;   Drug: Enalapril;   Drug: Placebo to LCZ696;   Drug: Placebo to Enalapril
2 Recruiting AZD0585 Phase III Long-term Study in Japan
Condition: Hypertriglyceridemia,
Interventions: Drug: AZD0585;   Drug: AZD0585 placebo
3 Recruiting Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: S-1;   Radiation: Radiation Therapy
4 Recruiting Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Linagliptin;   Drug: Empagliflozin placebo + linagliptin placebo;   Drug: Empagliflozin + linagliptin low dose;   Drug: Linagliptin lacebo;   Drug: Empagliflozin + linagliptin high dose
5 Recruiting A Study to Evaluate Dose-responses of Efficacy and Safety of ASP0456 in Patient With Chronic Constipation
Condition: Chronic Constipation
Interventions: Drug: ASP0456;   Drug: Placebo
6 Not yet recruiting A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP)
Condition: Diabetic Peripheral Neuropathic Pain
Interventions: Drug: Duloxetine;   Drug: Pregabalin;   Drug: Placebo
7 Recruiting Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
Condition: Contraception
Intervention: Drug: Levonorgestrel (BAY98-7196)
8 Recruiting Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Avelumab;   Drug: Docetaxel
9 Recruiting A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)
Condition: Rheumatoid Arthritis
Interventions: Drug: sarilumab SAR153191 (REGN88);   Drug: non-MTX DMARDs (e.g. sulfasalazine, leflunomide, bucillamine, tacrolimus, or mizoribin);   Drug: sulfasalazine;   Drug: leflunomide;   Drug: bucillamine;   Drug: tacrolimus;   Drug: mizoribin
10 Recruiting Daily Use of JARDIANCE® Tablets in Japanese Elderly Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Jardiance
11 Recruiting A Global Study to Assess the Effects of MEDI4736, Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer (NSCLC)
Interventions: Drug: MEDI4736;   Drug: Vinorelbine;   Drug: Gemcitabine;   Drug: Erlotinib;   Drug: MEDI4736 in combination with tremelimumab (anti-CTLA4);   Drug: tremelimumab (anti-CTLA4)
12 Recruiting An Efficacy and Safety Study of CNTO1959 (Guselkumab) in the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
Condition: Pustular Psoriasis
Intervention: Drug: Guselkumab
13 Recruiting A Phase 2 Dose-finding Study of TAK-272 in Patients With Type 2 Diabetes Mellitus and Microalbuminuria
Condition: Type 2 Diabetes Mellitus and Microalbuminuria
Interventions: Drug: TAK-272 tablets;   Drug: Placebo tablets;   Drug: Candesartan cilexetil tablets
14 Recruiting Study of Efficacy and Safety of Omalizumab in Refractory Chronic Spontaneous Urticaria Patients
Condition: Chronic Spontaneous Uriticaria
Interventions: Biological: Omalizumab;   Other: Placebo
15 Recruiting An Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type Psoriasis
Condition: Psoriasis
Interventions: Drug: CNTO 1959 50 mg;   Drug: CTNO 1959 100 mg;   Drug: Placebo 50 mg;   Drug: Placebo 100 mg
16 Recruiting Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS)
Condition: Stroke
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Aspirin (Acetylsalicylic acid, BAY1019036);   Other: Rivaroxaban-Placebo;   Other: Aspirin-Placebo
17 Recruiting Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration
Condition: Wet Macular Degeneration
Intervention: Drug: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
18 Recruiting A Study of MPDL3280A Compared With Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: Chemotherapy;   Drug: MPDL3280A
19 Recruiting Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: olodaterol;   Drug: tiotropium
20 Recruiting A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI)
Condition: Rheumatoid Arthritis
Interventions: Drug: sarilumab SAR153191 (REGN88);   Other: placebo;   Drug: methotrexate;   Drug: folic acid

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years